A carregar...
Critical reappraisal of remdesivir investigational trials in COVID-19
During disease outbreaks, the pharmaceutical industry generally puts a lot of effort into promoting clinical trials studying their new drugs. We review evidence of the ten most recent reports on remdesivir. We conclude that it is far too premature to identify remdesivir as a curative or life-saving...
Na minha lista:
| Publicado no: | New Microbes New Infect |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7567956/ https://ncbi.nlm.nih.gov/pubmed/33088576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nmni.2020.100745 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|